These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31775675)

  • 1. Dual time point
    Yamagishi Y; Koiwai T; Yamasaki T; Einama T; Fukumura M; Hiratsuka M; Kono T; Hayashi K; Ishida J; Ueno H; Tsuda H
    BMC Cancer; 2019 Nov; 19(1):1146. PubMed ID: 31775675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Dual Time Point
    Einama T; Yamagishi Y; Takihata Y; Konno F; Kobayashi K; Yonamine N; Fujinuma I; Tsunenari T; Kouzu K; Nakazawa A; Iwasaki T; Shinto E; Ishida J; Ueno H; Kishi Y
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?
    Basu S; Mavi A; Cermik T; Houseni M; Alavi A
    Mol Imaging Biol; 2008; 10(1):62-6. PubMed ID: 18000713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the standardized uptake value maximum change calculated by dual-time-point (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer.
    Jin F; Zhu H; Fu Z; Kong L; Yu J
    Onco Targets Ther; 2016; 9():2993-9. PubMed ID: 27284249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E
    Clin Radiol; 2008 Nov; 63(11):1213-27. PubMed ID: 18929039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of
    Yamagishi Y; Yamasaki T; Ishida J; Moriya T; Einama T; Koiwai T; Fukumura-Koga M; Kono T; Hayashi K; Ueno H; Yamamoto J; Tsuda H
    Ann Surg Oncol; 2020 Aug; 27(8):2698-2710. PubMed ID: 32124121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Clinical Molecular Typing of Breast Invasive Ductal Carcinoma Using
    Zhang J; Liu Y; Fan H; Wang W; Shao W; Cao G; Shi X
    Acad Radiol; 2023 Sep; 30 Suppl 2():S82-S92. PubMed ID: 36624021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT.
    Sasada S; Masumoto N; Kimura Y; Kajitani K; Emi A; Kadoya T; Okada M
    AJR Am J Roentgenol; 2019 Nov; 213(5):1129-1135. PubMed ID: 31339353
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.
    Andreou D; Boldt H; Pink D; Jobke B; Werner M; Schuler M; Reichardt P; Tunn PU
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1076-83. PubMed ID: 24519553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The maximum standardized uptake value increment calculated by dual-time-point
    Yonezawa N; Minamikawa T; Kitajima K; Takahashi Y; Sasaki R; Nibu KI; Komori T
    Nagoya J Med Sci; 2017 Feb; 79(2):189-198. PubMed ID: 28626254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point
    Yoo J; Yoon HJ; Kim BS
    J Womens Health (Larchmt); 2017 Oct; 26(10):1131-1137. PubMed ID: 28498790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results.
    Buchbender C; Kuemmel S; Hoffmann O; Stahl AR; Kimmig R; Otterbach F; Ladd S; Koeninger A; Forsting M; Bockisch A; Antoch G; Heusner TA
    Acta Radiol; 2012 Jul; 53(6):628-36. PubMed ID: 22761341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
    Yoo J; Kim BS; Chung J; Yoon HJ
    Medicine (Baltimore); 2017 Aug; 96(31):e7657. PubMed ID: 28767583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Values of Different Evaluation Criteria of Interim
    Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
    Aogi K; Kadoya T; Sugawara Y; Kiyoto S; Shigematsu H; Masumoto N; Okada M
    Breast Cancer Res Treat; 2015 Feb; 150(1):209-17. PubMed ID: 25697596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer.
    Ikejiri H; Sasada S; Emi A; Masumoto N; Kadoya T; Okada M
    Breast; 2022 Oct; 65():98-103. PubMed ID: 35921799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of interim
    Yuan L; Kreissl MC; Su L; Wu Z; Hacker M; Liu J; Zhang X; Bo Y; Zhang H; Li X; Li S
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):478-488. PubMed ID: 30382301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Predictive Value of Early Changes in
    He M; Liu C; Shi Q; Sun Y; Zhang Y; Xu X; Yuan H; Zhang Y; Liu Y; Liu G; Di G; Yang Z; Wang Z; Shao Z
    Oncologist; 2020 Nov; 25(11):927-936. PubMed ID: 32272493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.